Ken Griffin Bio Xcel Therapeutics, Inc. Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$0.53 - $1.34 $20,193 - $51,054	-38,100 Reduced 57.9%	27,700 $16,000
Q2 2024 Aug 14, 2024	SELL	$1.14 - $2.97 $13,565 - $35,343	-11,900 Reduced 15.32%	65,800 $84,000
Q1 2024 May 15, 2024	SELL	$1.95 - $4.04 $21,840 - $45,248	-11,200 Reduced 12.6%	77,700 $219,000
Q4 2023 Feb 14, 2024	SELL	$2.32 - $5.51 $41,992 - $99,731	-18,100 Reduced 16.92%	88,900 $262,000
Q3 2023 Nov 14, 2023	BUY	$2.49 - $11.85 $51,045 - $242,925	20,500 Added 23.7%	107,000 $270,000
Q2 2023 Aug 14, 2023	BUY	$6.39 - $28.58 $462,636 - $2.07 Million	72,400 Added 513.48%	86,500 $576,000
Q1 2023 May 15, 2023	SELL	$17.7 - $33.24 $157,530 - $295,836	-8,900 Reduced 38.7%	14,100 $263,000
Q4 2022 Feb 14, 2023	BUY	$10.25 - $22.43 $30,750 - $67,290	3,000 Added 15.0%	23,000 $494,000
Q3 2022 Nov 14, 2022	SELL	$11.19 - $17.89 $247,299 - $395,369	-22,100 Reduced 52.49%	20,000 $236,000

3.14M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $14.3M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.